Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function

Journal of Immunology

Volumn 163, Issue 1, 1999, Pages 434-442

  Jimi, Eijiro ^a   Akiyama, Shuichi ^a   Tsurukai, Taro ^a   Okahashi, Nobuo ^b   Kobayashi, Kanichiro ^a   Udagawa, Nobuyuki ^a   Nishihara, Tatsuji ^b   Takahashi, Naoyuki ^a   Suda, Tatsuo ^a  

^a SHOWA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL SURVIVAL; GROWTH REGULATION; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN DETERMINATION;

ACID PHOSPHATASE; ANIMALS; BONE MARROW CELLS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CARRIER PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; DENTIN; INTERLEUKIN-1; ISOENZYMES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MEMBRANE GLYCOPROTEINS; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; OSTEOCLASTS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033168518     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Chambers, T. J., P. A. Revell, K. Fuller, and N. A. Athanasou. 1984. Resorption of bone by isolated rabbit osteoclasts. J. Cell Sci. 66:383.
2. Baron, R., L. Neff, D. Louvard, and P. J. Courtoy. 1985. Cell-mediated extracellular acidification and bone resorption: evidence for a low pH in resorbing lacunae and localization of a 100-kD lysosomal membrane protein at the osteoclast ruffled border. J. Cell Biol. 101:2210.
3. Suda, T., N. Udagawa, and N. Takahashi. 1996. Osteoclast generation. In Principles of Bone Biology. L. G. Raisz, G. A. Rodan, and J. P. Bilezikian, eds. Academic Press, San Diego, CA, p. 87.
4. Jimi, E., I. Nakamura, H. Amano, Y. Taguchi, T. Tsurukai, M. Tamura, N. Takahashi, and T. Suda. 1996. Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact. Endocrinology 137:2187.
5. Jimi, E., T. Shuto, and T. Koga. 1995. Macrophage colony-stimulating factor and interleukin-1 α maintain the survival of osteoclast-like cells. Endocrinology 136: 808.
6. Jimi, E., I. Nakamura, T. Ikebe, S. Akiyama, N. Takahashi, and T. Suda. 1998. Activation of NF-κB is involved in the survival of osteoclasts promoted by interleukin-1. J. Biol. Chem. 273:8799.
7. Jimi, E., I. Nakamura, L. T. Duong, T. Ikebe, N. Takahashi, G. A. Rodan, and T. Suda. 1999. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells. Exp. Cell Res. 247:84.
8. Simonet, W. S., D. L. Lacey, C. R. Dunstan, M. Kelley, M. S. Chang, R. Luthy, H. Q. Nguyen, S. Wooden, L. Bennett, T. Boone, et al. 1997. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309.
9. Tsuda, E., M. Goto, S. Mochizuki, K. Yano, F. Kobayashi, T. Morinaga, and K. Higashio. 1997. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem. Biophys. Res. Commun. 234:137.
10. Yasuda, H., N. Shima, N. Nakagawa, K. Yamaguchi, M. Kinosaki, S. Mochizuki, A. Tomoyasu, K. Yano, M. Goto, A. Murakami, et al. 1997. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. USA 95:3597.
11. Wong, B. R., J. Rho, J. Arron, E. Robinson, J. Orlinick, M. Chao, S. Kalachikov, E. Cayani, F. S. Bartlett III, W. N. Frankel, S. Y. Lee, and Y. Choi. 1997. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J. Biol. Chem. 272:25190.
12. Anderson, D. M., E. Maraskovsky, W. L. Billingsley, W. C. Dougall, M. E. Tometsko, E. R. Roux, M. C. Teepe, R. F. DuBose, D. Cosman, and L. Galibert. 1997. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390:175.
13. Lacey, D. L., E. Timms, H.-L. Tan, M. J. Kelley, C. R. Dunstan, T. Burgess, R. Elliott, A. Colombero, G. Elliott, S. Scully, et al. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165.
14. Fuller, K., B. Wong, S. Fox, Y. Choi, and T. J. Chambers. 1998. TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J. Exp. Med. 188:997.
15. 3 in osteoclast differentiation and function. Methods Enzymol. 282:223.
16. Wesolowski, G., L. T. Duong, P. T. Lakkakorpi, R. M. Nagy, K. Tezuka, H. Tanaka, G. A. Rodan, and S. B. Rodan. 1995. Isolation and characterization of highly enriched, prefusion mouse osteoclastic cells. Exp. Cell Res. 219:679.
17. Yamashita, T., K. Asano, N. Takahashi, T. Akatsu, N. Udagawa, T. Sasaki, T. J. Martin, and T. Suda. 1990. Cloning of an osteoblastic cell line involved in the formation of osteoclast-like cells. J. Cell Physiol. 145:587.
18. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase 11 in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475.
19. +-ATPase trigger apoptotic cell death of osteoclasts. J. Bone Miner. Res. 12:1116.
20. Mizushima, S., and S. Nagata. 1990. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res. 18:5322.
21. Nakagawa, N., M. Kinosaki, K. Yamaguch, N. Shima, H. Yasuda, K. Yano, T. Morinaga, and K. Higashio. 1998. RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis. Biochem. Biophys. Res. Commun. 251:395.
22. Baker, S. J., and E. P. Reddy. 1996. Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 12:1.
23. Wong, B. R., R. Josien, S. Y. Lee, B. Sauter, H. L. Li, R. M. Steinman, and Y. Choi. 1997. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J. Exp. Med. 186:2075.
24. Cas is involved in actin organization in osteoclasts. J. Biol. Chem. 273:11144.
25. Nophar, Y., O. Kemper, C. Brakebusch, H. Englemann, R. Zwang, D. Aderlka, H. Holtmann, and D. Wallach. 1990. Soluble forms of tumor necrosis factor receptors (TNF-Rs): the cDNA for the type I TNF-R. cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor. EMBO J. 9:3269.
26. Smith, C., L. Lauffer, T. Davis, M. Widner, S. Dower, C. Jacobs, K. Mohler, and R. G. Goodwin. 1991. Cytokines 3:448.
27. Ashkenazi, A., S. A. Marsters, D. J. Capon, S. M. Chamow, I. S. Figari, D. Pennica, D. V. Goeddel, M. A. Palladino, and D. H. Smith. 1991. Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin. Proc. Natl. Acad. Sci. USA 88:10535.
28. Peppel, K., D. Crawford, and B. Beutler. 1991. A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity. J. Exp. Med. 174:1483.
29. Tanaka, S., N. Takahashi, N. Udagawa, T. Tamura, T. Akatsu, E. R. Stanley, T. Kurokawa, and T. Suda. 1993. Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors. J. Clin. Invest. 91:257.
30. Hentunen, T. A., S. V. Reddy, B. F. Boyce, R. Devlin 9, H. R. Park, H. Chung, K. S. Selander, M. Dallas, N. Kurihara, D. L. Galson, S. R. Goldring, B. A. Koop, J. J. Windle, and G. D. Roodman. 1998. Immortalization of osteoclast precursors by targeting Bcl-XL and Simian virus 40 large T antigen to the osteoclast lineage in transgenic mice. J. Clin. Invest. 102:88.
31. Okahashi, N., M. Koide, E. Jimi, T. Suda, and T. Nishihara. 1998. Caspases (interleukin-1β-converting enzyme family proteases) are involved in the regulation of the survival of osteoclasts. Bone 23:33.
32. Beg, A. A., and D. Baltimore. 1996. An essential role for NF-κB in preventing TNFα-induced cell death. Science 274:782.
33. Wang, C. Y., M. W. Mayo, and A. S. Baldwin, Jr. 1996. TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 274:784.
34. Van Antwerp, D. J., S. J. Martin, T. Kafri, D. R. Green, and I. M. Verma. 1996. Suppression of TNFα-induced apoptosis by NF-κB. Science 274:787.
35. Liu, Z. G., H. Hsu, D. V. Goeddel, and M. Karin. 1996. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87:565.
36. Ozaki, K., H. Takeda, H. Iwahashi, S. Kitano, and S. Hanazawa. 1997. NF-κB inhibitors stimulate apoptosis of rabbit mature osteoclasts and inhibit bone resorption by these cells. FEBS Lett. 410:297.
37. Zanke, B. W., K. Boudreau, E. Rubie, E. Winnett, L. A. Tibbles, L. Zon, J. Kyriakis, F. F. Liu, and J. R. Woodgett. 1996. The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat. Curr. Biol. 6:606.
38. Dickens, M., J. S. Rogers, J. Cavanagh, A. Raitano, Z. Xia, J. R. Halpern, M. E. Greenberg, C. L. Sawyers, and R. J. Davis. 1997. A cytoplasmic inhibitor of the JNK signal transduction pathway. Science 277:693.
39. Arch, R. H., R. W. Gedrich, and C. B. Thompson. 1998. Tumor necrosis factor receptor-associated factors (TRAFs): a family of adapter proteins that regulates life and death. Genes Dev. 12:2821.
40. Nishina, H., K. D. Fischer, L. Radvanyi, A. Shahinian, R. Hakem, E. A. Rubie, A. Bernstein, T. W. Mak, J. R. Woodgett, and J. M. Penninger. 1997. Stress-signalling kinase Sek1 protects thymocytes from apoptosis mediated by CD95 and CD3. Nature 185:350.
41. Lee, S. Y., A. Reichlin, A. Santana, K. A. Sokol, M. C. Nussenzweig, and Y. Choi. 1997. TRAF2 is essential for JNK but not NF-κB activation and regulates lymphocyte proliferation and survival. Immunity 7:703.
42. Yeh, W.-C., A. Shahinian, D. Speiser, J. Kraunus, F. Billia, A. Wakeh am, J. L. de la Pompa, D. Ferrick, B. Hum, N. Iscove, P. Ohashi, M. Rothe, D. V. Goeddel, and T. W. Mak. 1997. Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7:715.
43. Lee, S. Y., D. R. Kaufman, A. L. Mora, A. Santana, M. Boothby, and Y. Choi. 1998. Stimulus-dependent synergism of the antiapoptotic tumor necrosis factor receptor-associated factor 2 (TRAF2) and nuclear factor κB pathways. J. Exp. Med. 188:1381.
44. Xu, L. X., T. Kukita, Y. Nakano, H. Yu, T. Hotokebuchi, T. Kuratani, T. Iijima, and T. Koga. 1996. Osteoclasts in normal and adjuvant arthritis bone tissues express the mRNA for both type I and II interleukin-1 receptors. Lab. Invest. 75:677.
45. Bucay, N., I. Sarosi, C. R. Dunstan, S. Morony, J. Tarpley, C. Capparelli, S. Scully, H. L. Tan, W. Xu, D. L. Lacey, W. J. Boyle, and W. S. Simonet. 1998. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev. 12:1260.
46. Darnay, B. G., V. Haridas, J. Ni, P. A. Moore, and B. B. Aggarwal. 1998. Characterization of the intracellular domain of receptor activator of NF-κB (RANK): interaction with tumor necrosis factor receptor-associated factors and activation of NF-κB and c-Jun N-terminal kinase. J. Biol. Chem. 273:20551.
47. Wong, B. R., R. Josien, S. Y. Lee, M. Vologodskaia, R. M. Steinman, and Y. Choi. 1998. The TRAF family of signal transducers mediates NF-κB activation by the TRANCE receptor. J. Biol. Chem. 273:28355.
48. Galibert, L., M. E. Tometsko, D. M. Anderson, D. Cosman, and W. C. Dougall. 1998. The involvement of multiple tumor necrosis factor receptor (TNF)-associated factors in signaling mechanisms of receptor activation of NF-κB, a member of the TNFR superfamily. J. Biol. Chem. 273:34120.
49. Damay, B. G., J. Ni, P. A. Moore, and B. B. Aggarwal. 1999. Activation of NF-κB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-κB-inducing kinase: identification of a novel TRAF6 interaction motif. J. Biol. Chem. 274:7724.
50. Iotsova, V., J. Caamano, J. Loy, Y. Yang, A. Lewin, and R. Bravo. 1997. Osteopetrosis in mice lacking NF-κB1 and NF-κB2. Nat. Med. 3:1285.
51. Franzoso, G., L. Carlson, L. Xing, L. Poljak, E. W. Shores, K. D. Brown, A. Leonardi, T. Tran, B. F. Boyce, and U. Siebenlist. 1997. Requirement for NF-κB in osteoclast and B-cell development. Genes Dev. 11:3482.